Healthcare / Medical Care FacilitiesSaudi
$8.00
+0.03 (+0.38%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-2.1M · quality 61.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
14/100
F
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
8/100
SEC 0%
Sin guardar todavía.
Market Cap
$320M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-22.1%
↓Gross Margin
23.9%
↓Debt/Equity
0.69
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2024–2025 · 1 años de histórico normalizado
Revenue CAGR
-4.5%
FCF CAGR
—
FCF margin
-3.7%
FCF / Net income
0.65x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $183.1M · net income $-10.3M · FCF $-6.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 |
|---|---|---|---|
| Income Statement | |||
| Revenue | $183.1M | $183.1M | $191.8M |
| Net Income | $-10.3M | $-10.3M | $23.5M |
| EBITDA | $-2.3M | $-2.3M | $29.5M |
| EPS | — | — | 0.59 |
| Gross Margin | 23.9% | 23.9% | 31.6% |
| Operating Margin | -3.7% | -3.7% | 13.3% |
| Net Margin | -5.6% | -5.6% | 12.3% |
| Balance Sheet | |||
| Debt/Equity | 0.69 | 0.69 | 0.20 |
| Current Ratio | 1.44 | 1.44 | — |
| Cash Flow | |||
| Free Cash Flow | $-6.7M | $-6.7M | $2.5M |
| Returns | |||
| ROE | -22.1% | -22.1% | 35.0% |
| Valuation | |||
| P/B | 6.86 | 6.86 | — |
| Growth & Yield | |||
| Revenue Growth | -4.5% | -4.5% | — |
| Dividend Yield | 3.1% | 3.1% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-54.1%
Start / end P/E
n/dx → n/dx
EPS bridge
0.59 → n/d
Residual
-57.3%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.